25
2016-01Professor BRECHOT, President of INSTITUT PASTEUR visit IPS On January 19, 2016 the Director of the Institut Pasteur Christian Brechot visited IPS-CAS. He was warmly welcomed by Hong Tang, IPS Director General, together with Fernando Arenzana, IPS Scientific co-Director. IPS past achievements and the future scientific plan of the institute in the context ...
08
2016-01On December 30, 2015, the Journal of Virology published an advanced research work, entitled “Human mucosal mast cells capture HIV-1 and mediate viral trans-infection of CD4+ T cells”, from Jian-Hua WANG`s Lab, Institute Pasteur of Shanghai, Chinese Academy of Sciences. This work reveals a novel...On December 30, 2015, the Journal of Virology published an advanced research work, entitled “Human mucosal mast cells capture HIV-1 and mediate viral trans-infection of CD4+ T cells”, from Jian-Hua WANG`s Lab, Institute Pasteur of Shanghai, Chinese Academy of Sciences. This work reveals a novel...
04
2016-01On December 29,the French Minister of State for Higher Education and Research, Mr. Thierry Mandon visited Institut Pasteur of Shanghai. An overview of the history of IPS and a general discussion on the latest achievements was held in the fields of basic/applied research, public health and educati...On December 29, the French Minister of State for Higher Education and Research, Mr. Thierry Mandon visited Institut Pasteur of Shanghai. An overview of the history of IPS and a general discussion on the latest achievements was held in the fields of basic/applied research, public health and educat...
11
2015-11Kaposi’s sarcoma-associated herpesvirus (KSHV), known as human herpesvirus 8 (HHV8), is the etiological agent of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castelman’s disease (MCD). KSHV has developed a unique mechanism to subvert host antiviral immune responses b...Kaposi’s sarcoma-associated herpesvirus (KSHV), known as human herpesvirus 8 (HHV8), is the etiological agent of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castelman’s disease (MCD). KSHV has developed a unique mechanism to subvert host antiviral immune responses b...